Histamine Brain Pathways and Psychiatric Disorders

This new histamine brain pathways study maps how histamine-related genes are distributed across the human brain and how those patterns relate to cognition, emotion, sleep, and psychiatric disorders. The findings suggest histamine may play a broader systems-level role in brain organization than previously appreciated. Importantly, the study is correlational and hypothesis-generating, not proof that histamine dysfunction causes psychiatric disease.

Read More

When Ketogenic Diet Therapy Is Added After CBD

CBD ketogenic diet epilepsy research is beginning to clarify how two established seizure-focused strategies may work together. A Johns Hopkins retrospective chart review suggests that adding ketogenic diet therapy after CBD is already established may offer a clinically relevant sequencing signal in pharmacoresistant epilepsy. The finding is not definitive, but it gives patients, families, and clinicians a more precise question to ask when CBD alone is not enough.

Read More

Cannabis, Tics, Tourette Syndrome, and OCD Symptoms

Medical cannabis for tic disorders may help some adults with Tourette syndrome or chronic tics, but the evidence is still developing. This guide explains why tics, compulsions, anxiety, and OCD symptoms can overlap while still requiring different clinical thinking. It reviews THC, CBD, behavioral therapy, safety concerns, pediatric caution, and how to track whether cannabis is truly helping.

Read More

What Federal Cannabis Rescheduling Means for Care

Cannabis Schedule III rescheduling marks a major shift in how cannabis is classified and understood at the federal level. This change begins to align policy with clinical reality, affecting research, documentation, and patient access. Cannabis Schedule III rescheduling does not solve every clinical challenge, but it opens the door to more structured and evidence-driven care.

Read More